Chava Perry
Impact in
-
- Lymphoma Diagnosis and Treatment
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 33
- Oncology 30
- CAR-T cell therapy research 18
- Co-authors
- Hermona Soreq (13 shared papers)Irit Avivi (39 shared papers)Aaron Polliack (13 shared papers)Yair Herishanu (33 shared papers)Ella H. Sklan (5 shared papers)Einat Even‐Sapir (8 shared papers)Amiram Eldor (6 shared papers)Elizabeth Naparstek (13 shared papers)
- Journals
- Blood (11 papers)Leukemia Research (5 papers)Annals of Hematology (5 papers)British Journal of Haematology (4 papers)European Journal Of Haematology (4 papers)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Chava Perry
81 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 102
- Pathology and Forensic Medicine 460
- Genetics 192
- Oncology 455
- Pharmacology 236
- Hematology 150
Countries citing papers authored by Chava Perry
This map shows the geographic impact of Chava Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chava Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chava Perry more than expected).
Fields of papers citing papers by Chava Perry
This network shows the impact of papers produced by Chava Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chava Perry. The network helps show where Chava Perry may publish in the future.
Co-authors
The 25 scholars most cited alongside Chava Perry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 127 | |
| 2 | 1997 | 94 | |
| 3 | 2021 | 94 | |
| 4 | 2007 | 92 | |
| 5 | 2002 | 78 | |
| 6 | 2017 | 75 | |
| 7 | 2002 | 72 | |
| 8 | 2004 | 62 | |
| 9 | 2003 | 61 | |
| 10 | 2002 | 59 | |
| 11 | 2006 | 55 | |
| 12 | 2021 | 50 | |
| 13 | 2021 | 49 | |
| 14 | 2007 | 49 | |
| 15 | 2005 | 46 | |
| 16 | 2002 | 46 | |
| 17 | 2021 | 41 | |
| 18 | 2012 | 40 | |
| 19 | 2013 | 40 | |
| 20 | 2021 | 36 |
About Chava Perry
Chava Perry is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Molecular Biology and Immunology, having authored 88 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (33 papers), Chronic Lymphocytic Leukemia Research (23 papers), CAR-T cell therapy research (18 papers), Cholinesterase and Neurodegenerative Diseases (10 papers), CNS Lymphoma Diagnosis and Treatment (7 papers), Immunodeficiency and Autoimmune Disorders (5 papers), Computational Drug Discovery Methods (5 papers) and Medical Imaging Techniques and Applications (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (460 citations), Genetics (192 citations), Oncology (455 citations), Pharmacology (236 citations) and Hematology (150 citations). Chava Perry has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Hermona Soreq, Irit Avivi, Aaron Polliack, Yair Herishanu, Ella H. Sklan, Einat Even‐Sapir, Amiram Eldor, Elizabeth Naparstek, Sigi Kay and Varda Deutsch. Their work appears in journals such as Blood, Leukemia Research, Annals of Hematology, British Journal of Haematology and European Journal Of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.